Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B-Reference-Cited by-同舟云学术

Comparison of Lamivudine Plus Adefovir Therapy Versus Entecavir With or Without Adefovir Therapy for Adefovir-resistant Chronic Hepatitis B

Published:2014-11 Issue:10 Volume:48 Page:889-895
ISSN:0192-0790
Container-title:Journal of Clinical Gastroenterology
language:en
Short-container-title:

Author:

Kang Seong Hee,Yim Hyung Joon,Kim Hae Rim,Kang Keunhee,Suh Sang Jun,Lee Hyun Jung,Yoon Eileen L.,Kim Ji Hoon,Seo Yeon Seok,Yeon Jong Eun,Byun Kwan Soo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology

Reference34 articles.

1. . Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection.;Lee;Cancer,1999

2. Hepatitis B virus infection.;Lee;N Engl J Med,1997

3. From hepatitis to hepatoma: lessons from type B viral hepatitis.;Chen;Science,1993

4. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.;Liaw;Liver Int,2009

5. . Long-term safety of lamivudine treatment in patients with chronic hepatitis B.;Lok;Gastroenterology,2003

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B;The Korean Journal of Gastroenterology;2021-01-25

2. Maintaining Antiviral Efficacy after Switching to Generic Entecavir 1 mg for Antiviral-resistant Chronic Hepatitis B;KOR J GASTROENTEROL;2021

3. Factors associated with disease progression and viral replication in patients with chronic hepatitis B virus infection;Experimental and Therapeutic Medicine;2019-04-11

4. Entecavir-based combination therapies for chronic hepatitis B;Medicine;2018-12

5. A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study;British Journal of Clinical Pharmacology;2017-06-18